Premium
Molbio Diagnostics, a point-of-care diagnostics firm backed by Motilal Oswal Private Equity, is slated to close the current financial year at break-even and with a 30X surge in revenues on the back of growth fueled by the COVID-19 pandemic, a top company official told VCCircle. The Goa based company, which makes ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
